title: Propranolol for complicated infantile haemangiomas: a case series of 30 infants.
authors.forename: F
authors.initials: F
authors.lastname: Manunza
authors.forename: S
authors.initials: S
authors.lastname: Syed
authors.forename: B
authors.initials: B
authors.lastname: Laguda
authors.forename: J
authors.initials: J
authors.lastname: Linward
authors.forename: H
authors.initials: H
authors.lastname: Kennedy
authors.forename: K
authors.initials: K
authors.lastname: Gholam
authors.forename: M
authors.initials: M
authors.lastname: Glover
authors.forename: A
authors.initials: A
authors.lastname: Giardini
authors.forename: J I
authors.initials: JI
authors.lastname: Harper
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D005142:Eyelid Neoplasms / Q000188:drug therapy; D005153:Facial Neoplasms / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D005931:Glottis; D018324:Hemangioma, Capillary / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008297:Male; D011433:Propranolol / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol